Received Mar 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
she had aches/pain; Fever; eyes hurt; tired; headache; not feeling well; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in a female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced pain (Verbatim: she had aches/pain), fever (Verbatim: Fever), eye pain (Verbatim: eyes hurt), tiredness (Verbatim: tired), headache (Verbatim: headache) and feeling unwell (Verbatim: not feeling well). The outcome of the pain, fever, eye pain, tiredness, headache and feeling unwell were unknown. It was unknown if the reporter considered the pain, fever, eye pain, tiredness, headache and feeling unwell to be related to Boostrix. It was unknown if the company considered the pain, fever, eye pain, tiredness, headache and feeling unwell to be related to Boostrix. Linked case(s) involving the same patient: US2026036133 Additional Information: GSK Receipt Date:17-MAR-2026 This case was linked with US2026036133, reported by same reporter, for a different suspect of same patient. The batch number was not provided and we unable to contact the reporter.; Sender's Comments: US-GSK-US2026036133:
Test Name: Body temperature; Result Unstructured Data: (Test Result:102,Unit:degree F,Normal Low:,Normal High:)